Tevogen Bio Holdings Files 8-K
Ticker: TVGNW · Form: 8-K · Filed: Apr 17, 2025 · CIK: 1860871
| Field | Detail |
|---|---|
| Company | Tevogen Bio Holdings Inc. (TVGNW) |
| Form Type | 8-K |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: TVGN
TL;DR
Tevogen Bio Holdings filed a standard 8-K, no major news.
AI Summary
Tevogen Bio Holdings Inc. filed an 8-K on April 17, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Tevogen Bio Holdings Inc. is meeting its regulatory reporting obligations. Investors should review the exhibits for any specific disclosures.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain information that inherently increases risk.
Key Players & Entities
- Tevogen Bio Holdings Inc. (company) — Registrant
- Semper Paratus Acquisition Corp (company) — Former company name
- 15 Independence Boulevard, Suite 410 (location) — Business and mailing address
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is April 17, 2025.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
What was the former name of Tevogen Bio Holdings Inc.?
The former name of Tevogen Bio Holdings Inc. was Semper Paratus Acquisition Corp.
What is the business address of Tevogen Bio Holdings Inc.?
The business address of Tevogen Bio Holdings Inc. is 15 Independence Boulevard, Suite 410, Warren, NJ 07059.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 17, 2025 regarding Tevogen Bio Holdings Inc. (TVGNW).